Director, Regulatory Innovation Lead for RWE and Data Science
Bristol Myers Squibb
Rob Kalesnik-Orszulak is the Regulatory Innovation Lead for Real World Evidence (RWE) and Data Science at Bristol Myers Squibb (BMS). In this role, he has been responsible for building out the regulatory department's expertise, capabilities, and strategy around RWE from a regulatory perspective. As an experienced regulatory professional, Rob has led the regulatory strategy for multiple global filings/programs. A strong believer in the promise of technology in healthcare, Rob is passionate and excited about the future of health.
Disclosure information not submitted.
Tuesday, September 13, 2022
3:30 PM – 4:30 PM MST